Condensed Statement of Cash Flows (Unaudited)	3 Months Ended
	Mar. 31, 2026 USD ($)
Cash Flows from Operating Activities:
Net income	$ 1,684,199
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(1,987,373)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(51,321)
Short-term prepaid insurance	(116,125)
Long-term prepaid insurance	(88,967)
Accounts payable and accrued expenses	(4,514)
Accrued offering costs	(7,500)
Deferred legal fee payable	44,313
Net cash used in operating activities	(527,288)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(253,000,000)
Net cash used in investing activities	(253,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Public Units, net of underwriting discounts paid	250,470,000
Underwriters’ reimbursement	632,500
Proceeds from sale of Private Placements Warrants	5,000,000
Repayment of promissory note – related party	(165,580)
Payment of offering costs	(428,063)
Issuance of Representative Shares	1,000
Net cash provided by financing activities	255,509,857
Net Change in Cash	1,982,569
Cash – Beginning of period
Cash – End of period	1,982,569
Noncash investing and financing activities:
Offering costs included in accrued offering costs	82,500
Deferred legal fee payable	83,432
Fair value of representative shares charged to deferred offering costs and other assets	$ 9,839,000